NCT05122481 (VITA-C4CARE) is a NA clinical trial of Vitamin C in Hypovitaminosis, sponsored by University of Aberdeen.

Who is sponsoring NCT05122481?

NCT05122481 is sponsored by University of Aberdeen.

What drugs are being tested in NCT05122481?

Interventions in NCT05122481: Vitamin C.

What condition does NCT05122481 study?

NCT05122481 studies Hypovitaminosis, Vitamin C Abnormal.

Is NCT05122481 still recruiting?

NCT05122481 is currently status unknown. Last updated 18 May 2022.

Last reviewed 2022-05-18 · How we verify

NCT05122481: VITA-C4CARE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vitamin C 4 Care Homes

Status unknown NA Last updated 18 May 2022

What this trial tests

NA trial testing Vitamin C in Hypovitaminosis in 20 participants. Status unknown.

Timeline

15 January 2023

Primary endpoint
30 July 2023

30 July 2023

Quick facts

Lead sponsor	University of Aberdeen
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	20
Start date	15 January 2023
Primary completion	30 July 2023
Estimated completion	30 July 2023
Sites	1 location across United Kingdom

Drugs / interventions tested

Vitamin C — full drug profile →

Conditions studied

Hypovitaminosis — all drugs for Hypovitaminosis →
Vitamin C Abnormal — all drugs for Vitamin C Abnormal →

Sponsor

University of Aberdeen

Who can join

Adults 65 to 100, any sex, with Hypovitaminosis or Vitamin C Abnormal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Older people in care homes are one of the most vulnerable groups with respect to risk, morbidity and mortality of severe coronavirus disease-2019 (COVID-19). In the UK, almost half (47%) of all COVID-19 deaths occurred in care homes. The World Health Organization (WHO) has highlighted vitamin C as an adjunctive therapy with biological plausibility for people with severe COVID-19. Previous research has indicated that up to 40% of care home residents in the UK are deficient in vitamin C, an essential immune supportive nutrient. This is a 10-fold higher deficiency level than that reported in community dwelling older people in the UK government's National Diet and Nutrition Survey. Due to lack of robust pharmacokinetic data in older people, the intake required to optimise the vitamin C status of this cohort is not yet known and may be higher than that for healthy adults; some have estimated as high as 400 mg/d (the current UK recommended nutrient intake (RNI) or vitamin C is 40 mg/d, which is sufficient to prevent deficiency, but not enough for optimal/saturating vitamin C status). Thus, this pilot and feasibility study will assess the intake requirements of care home residents for optimal vitamin C status. The purpose is to provide essential data for a future clinical trial assessing the efficacy of optimal vitamin C supplementation for risk, severity, and duration of respiratory infections in this population who are at risk of such infections.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Vitamin C

Trials testing the same drug.

NCT07476443 — Renoprotective Role of Vitamin C and Coenzyme Q10 in Nephrotoxicity · Phase 2, PHASE3 · not yet recruiting
NCT07414693 — Effect of Vitamin C on Length of Hospital Stay in Children With Severe Pneumonia · Phase 4 · recruiting
NCT06971315 — Impact of Vitamin C on Pain Detection and Tolerance Threshold · NA · completed
NCT06794255 — Exploratory Study on the Role of Vitamin C in Promoting Health in Middle-Aged and Elderly Adults · NA · recruiting
NCT07341308 — Does Vitamin C Increase the Body Heat Generated By The Nervous System? · NA · recruiting

Other University of Aberdeen trials

Trials by the same sponsor.

NCT07070765 — Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity · NA · not yet recruiting
NCT07065383 — Rebalancing the Fat Content of the Heart and Muscles · NA · recruiting
NCT06735573 — Protein, Sarcopenic Obesity, and COPD · not yet recruiting
NCT06714656 — Drivers and Barriers for Adopting Healthy and Sustainable Food Swaps in Young · NA · recruiting
NCT06721312 — Continuous Heart Rate Variability Monitoring in Doctors; Understanding Patterns of Stress and Recovery and Their Relatio · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05122481 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Aberdeen
Last refreshed: 18 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05122481.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing